Biomaterial Database

[Reuse of implanted pacemakers]. 1994

H Grendahl

Avdeling for hjertesykdommer, Ullevål sykehus, Oslo.

One specific institution reports 310 cases of reuse of pacemakers from 1974 to 1993. 111 were obtained after replacement, and 199 after the death of the first user. The average duration of the primary implant was 12 months (0-53 months). 177 functioned up to time of death, 43 months (0-177 months). In 107 cases the cause of death was unrelated to use of a pacemaker, was unknown in 61, and was sudden in 9 patients. 64 pacemakers were replaced, 14 because of infections or skin erosions. The causes of death and the prevalence and indications for generator replacement coincided with those in our population of new pacemaker-users in 1988-93. CONCLUSIONS Pacemaker re-use in our hospital is safe and cost-effective.

UI	MeSH Term	Description	Entries
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D009664	Norway	A country located in northern Europe, bordering the North Sea and the Atlantic Ocean, west of Sweden. The capital is Oslo.	Kingdom of Norway
D010138	Pacemaker, Artificial	A device designed to stimulate, by electric impulses, contraction of the heart muscles. It may be temporary (external) or permanent (internal or internal-external).	Cardiac Pacemaker, Artificial,Artificial Cardiac Pacemaker,Artificial Cardiac Pacemakers,Artificial Pacemaker,Artificial Pacemakers,Cardiac Pacemakers, Artificial,Pacemaker, Artificial Cardiac,Pacemakers, Artificial,Pacemakers, Artificial Cardiac
D003362	Cost-Benefit Analysis	A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes.	Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D004869	Equipment Safety	Freedom of equipment from actual or potential hazards.	Device Safety,Hazards, Equipment,Medical Device Safety,Safety, Equipment,Device Safety, Medical,Safety, Medical Device,Equipment Hazard,Equipment Hazards,Hazard, Equipment,Safety, Device
D005260	Female		Females
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368	Aged	A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available.	Elderly
D017743	Equipment Reuse	Further or repeated use of equipment, instruments, devices, or materials. It includes additional use regardless of the original intent of the producer as to disposability or durability. It does not include the repeated use of fluids or solutions.	Product Recycling,Recycling, Equipment,Equipment Reusability,Equipment Recycling,Recycling, Product,Reusability, Equipment,Reuse, Equipment